Home > Boards > US Listed > Medical - Equipment > Titan Medical Inc. (TMDI)

Here you go BigK:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BigT82 Member Profile
 
Followed By 10
Posts 2,614
Boards Moderated 2
Alias Born 12/24/14
160x600 placeholder
Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders Business Wire - 6/10/2021 7:30:00 AM
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement GlobeNewswire Inc. - 5/28/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/24/2021 1:25:19 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/19/2021 8:02:42 AM
Titan Medical to Present at Oppenheimer MedTech Summit Investor Conference Business Wire - 5/19/2021 7:55:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/18/2021 7:43:53 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/17/2021 1:08:43 PM
Titan Medical reports Q1 results Seeking Alpha - 5/17/2021 7:48:22 AM
Titan Medical Reports First Quarter 2021 Financial Results and Provides Board Update Business Wire - 5/17/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/11/2021 2:53:42 PM
Titan Medical to Report First Quarter 2021 Financial Results May 17, 2021 Business Wire - 5/4/2021 7:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/26/2021 6:06:20 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/22/2021 7:31:27 AM
Titan Medical Expands Senior Leadership Team Business Wire - 4/22/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/16/2021 10:54:22 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/5/2021 7:31:18 AM
Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference Business Wire - 4/5/2021 7:30:00 AM
Annual Report (foreign Private Issuer) (40-f) Edgar (US Regulatory) - 4/1/2021 6:10:48 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 3/25/2021 6:05:18 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 3/18/2021 5:30:30 PM
Titan Medical to Participate in Upcoming Investor Conferences Business Wire - 3/10/2021 6:45:00 AM
Titan Medical provides corporate update ahead of investor conference Seeking Alpha - 3/9/2021 1:37:17 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/9/2021 9:56:55 AM
Titan Medical Issues Corporate Update Business Wire - 3/9/2021 6:45:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/26/2021 9:11:17 AM
BigT82   Friday, 04/09/21 07:10:11 PM
Re: BIGKAHUNA57 post# 126122
Post # of 128890 
Here you go BigK:

For those who are not familiar with BO calculations here schematicaly summarized.
1. Prospects of a Premarket Company are estimated regarding potential market share gain
2. Profitability is calculated on earnings before tax and depreciation
3. BO prize is calculated based on 1 + 2 and discounted (X%) and potentially leveraged due to strategic reasons.

Due to figures presented at the SRS by Goldman Sachs Global Investment research the Us Medical Robotics Market has been In 2019 and will grow to in 2025/2030 in Billion §:
# Soft Tissue Robotic Revenue 3,5/8,1/12,2
# Hard Tissue Robotic Revenue 0,3/ 1,1/1,7
# Flexibel Endoluminal Robotic Revenue 0,0/0,9/2,8

If Martha aims for minimum 25% marketshare cumulative revenue soft tissue for the years 2022 to 2028 would be about 15 Billion.
One can estimate that the rest of the world may contribute half the amount in total so we talk about 22 to 25 Billion for soft Tissue.
Lets assume profitability is minimum 30 % we came up with earnings 6 to 7 Billions. In this case I would guess strategic reasons equalize discounting. MDT payed 1,5 Billion for a 0,3 billion market. J&J payed 3,6 Billion for a non existing market.
I wonder what MDT will pay for the biggest market.
Thanks
Facetrain


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences